IV Ketamine FAQ

We aim to address your questions as you explore options and make informed decisions about your care.

Ketamine Facts: The Science Behind Ketamine’s Fast-Acting Effects.

Ketamine for depression

Ketamine is a medication approved by the United States Food and Drug Administration (FDA) for use as a general anesthetic, and has been administered safely for over 60 years in medical settings. The World Health Organization has designated ketamine as one of the 100 most essential drugs in the world. For over 20 years, research has shown that ketamine can provide rapid relief from depressive symptoms with minimal side-effects when administered intravenously at sub-anesthetic doses.

Find out if IV ketamine treatment for depression may be right for you.

With over 2,000 published papers and 137 clinical trials, ketamine is a well established treatment option for people managing depression. Globally, ketamine has been the single most studied drug for depression in the last 30 years. Ketamine helps depression through three complementary but distinct pathways that can result in feelings of profound relief, meaningful shifts in perspective, and the opportunity to make lasting change to behaviors and thinking patterns.

You can read more about ketamine for depression here and review the supporting evidence here.

Yes. Ketamine is used extensively in hospitals and clinics every day, and has been administered safely to millions of patients for decades. To ensure safety, ketamine infusions should be administered by medical professionals trained in anesthesia or emergency medicine.

If you still have safety questions or concerns, we invite you to read our safety section below.

Studies have shown that ketamine relieves depressive symptoms for 75% of patients with depression, including Major Depressive Disorder and Treatment-Resistant Major Depressive Disorder. CANMAT As an evidence-driven practice, Ember Health focuses on Depression and the depressive state of bipolar disorder.

Read more about who we can help here.

Ember Health is committed to defining and expanding access to the gold standard of care for depression, and to delivering the best outcomes and value to the people we serve. 

This has informed our commitment to evidence-based, patient-centered, partner-oriented care. These core concepts have directed decisions from focusing on IV administration, to providing 1:1 patient care, to only working in a partnership based model. 

Learn more about Ember Health’s unique model of care here and about ketamine for depression here.

Over the past 30 years, selective serotonin reuptake inhibitors (SSRIs) have been widely prescribed to address depression. SSRIs are based on the chemical imbalance theory of depression – that adding more serotonin to one’s system will lead to an improvement of mood. Literature supports that SSRIs have a 30 – 50% effectiveness rate for people with depression source . They require a steady state of medication in one’s system over time to have an effect. SSRIs often result in significant side effects and can take 6 to 12 weeks in the system before working. People often experience additional side effects when they stop taking SSRIs.

Ketamine benefits occur via the neural network theory of depression. Treatment leads to a structural reset of the emotional reward system in the brain. Patients who have a generally low baseline mood achieve a new neutral from which they can appropriately feel good when good things happen and appropriately feel bad when bad things happen. These new neural connections triggered by ketamine often begin within the first 72 hours. Literature supports that ketamine has a 75% efficacy rate for people with Treatment Resistant Depression. These positive results do not depend on the chemical staying in the body over time. Treatment results in very few-to-no side effects, and stopping treatment at the dosage and frequency we administer does not result in any unwanted side effects.

Patients have told us that while SSRIs may help stabilize their mood, they result in a “flatness”, “emotional numbness”, or a “mental fog.” Medication makes them feel less like themselves by dampening their emotions and therefore their depressive symptoms. These same patients have described how ketamine has helped them feel more like themselves by creating an emotional baseline to appropriately feel emotions and reframe core issues that have contributed to their depressive state.

All patients at Ember Health begin with a Foundational course of care, which consists of an in-person orientation visit, followed by four, 90-minute intravenous (IV) infusion appointments conducted over two weeks. Medical dosage protocols are based on what literature supports is the maximum antidepressant effect. Two weeks following the final infusion, a doctor from Ember’s team assesses treatment success based on mood survey data and additional inputs from the patient and their mental health team.

For the 86% of patients who have experienced relief from depressive symptoms, Ember Health conducts booster infusions at a cadence based on individual needs, on average, once every six weeks.

To learn more about how care works at Ember, see here. To learn how Ember Health follows the evidence and is contributing to care protocols through research partnerships, see here.

Each infusion appointment at Ember Health is 90 minutes long. Upon arrival, each patient is welcomed to a private infusion suite where a clinician will be with them throughout their entire visit.

Before the infusion, the clinician sets up the IV, and helps the patient establish a supportive mindset for care through intention-setting, aromatherapy, and music selection. 

The medication is administered for 40 minutes, based on evidence-driven protocols.

Following the infusion, the clinic opens the space for patients to reflect on their sessions through gentle inquiry, and providing an environment that feels safe and free from judgment.

At the end of the infusion, patients are welcomed into a common reflection and recovery area, where we have curated reading materials and activities based on patient request.

See here to read more about the patient experience at Ember.

During infusion, the most common side effect of ketamine is mild nausea. In rare cases, patients may experience allergic reactions, elevated blood pressures, elevated heart rate, or cardiac arrhythmia. A monitoring physician will intervene in the case of any of these effects FDA .

There are no known negative long-term effects of ketamine when used at the appropriate doses for depression and anesthesia. Select cases of long-term, daily use of ketamine by those who abuse the drug have shown some negative effects on the bladder and on cognition Yale .

Patients may start to experience relief within hours of treatment, and 95% of people who respond to ketamine for depression will have experienced at least some benefit by two weeks following their fourth foundational infusion.

About 25% patients start to feel relief after the first foundational infusion, 50% by the conclusion of the second, 75% by the end of the third, and the remaining responders up to two weeks following the foundation.

For most patients, ketamine relieves depressive symptoms for an average of six weeks after each infusion. Patients may receive booster infusions as depressive symptoms recur JAMA.

We work with each patient to identify a suitable maintenance program. Sometimes, this consists of a regular cadence of infusions according to a patient’s needs and schedule. Some patients find that their need for boosters becomes less frequent over time, prompting them to come in every 2 – 3 months. 

Ketamine boosters may be given for as long as needed with no known long-term side effects.

In some cases, patients experience full remission of their depressive symptoms and do not feel the need to seek continued treatment Yale. 

With that said, ketamine should not be considered a cure, but rather a powerful tool to manage depression over time. As stress and trauma over time erode neural connections in the brain, new exposures to ketamine are needed to prompt neural regrowth and reset the emotional reward system. 

See here how ketamine works for depression.

Ketamine is FDA approved for anesthesia, and is often considered “off-label” for depression. This is true for 60% of mental health drugs which are used off label of their mental health indications. 

While we are not aware of any healthcare insurers who cover IV ketamine for depression in-network, out-of-network insurance can significantly offset the cost of care at Ember Health.

On average, our clients who submit claims receive 70% reimbursement for our services. With that said, out-of-network reimbursement is notoriously confusing. See here our pricing page and see here guidelines on how to navigate out-of-network insurance.

Treatment Fit

At Ember Health, we work with people navigating Major Depressive Disorder and the Depressive state of Bipolar Disorder. 

If you have a formal diagnosis of depression, or believe you are depressed, we welcome you to set up a free consultation call with a doctor from our team who can help you determine whether ketamine might be a good option for you.

You may also take our online assessment to help you determine if treatment at Ember is right for you.

Labels in mental health can be challenging, and only you know how you feel.

At Ember Health, we work in a collaborative care model with licensed mental health professionals. We’ve partnered with over 2,000 mental health providers, and would be happy to connect you with professionals who could help you understand if what you’re experiencing is depression.

Most of our patients learn about us from their mental health care provider, as we only work with patients who are actively in care with at least one licensed mental health professional. 

With that being said, you do not need a formal referral to start care at Ember Health. Many of our patients have found us through their own research or word of mouth, and have introduced their mental health providers to us. 

If this applies to you, we encourage you to mention Ember Health to your provider team. They can learn how we partner here, and a doctor from our team is willing to connect with them over a call to share more about our care model and collaborative approach to treatment. 

Let us know! We have a database of over 2,000 excellent psychiatrists, therapists, primary care practitioners, NPs, and other professionals who we’d love to introduce you to. Email us at intake@emberhealth.co to inquire about providers we may recommend given your specific needs.

The majority of trials studying IV ketamine for depression have specifically focused on people managing Treatment Resistant Depression (TRD). By definition, these individuals have already failed at least two rounds of SSRI antidepressant medications. For this reason, many healthcare professionals will suggest starting with antidepressants before trying ketamine for depression.

With that said, people who do not want to try antidepressants first, based on their inferior outcomes data, length of time to take effect, and significant side-effect profile may still be eligible for ketamine as a first treatment step to treat their depression.

We recommend you speak with your mental health provider to consider your options, and a clinical member of our team would be happy to provide information to you or your mental health team about ketamine as an option for you.

At Ember Health, we’ve worked with patients as young as 14 and as old as 91.

Adolescent patients between the ages of 14 – 18 must also be working with an adolescent psychiatrist. We are accustomed to coordinating care with parents and care-givers.

Learn more about who we can help here.

There are no medical conditions that preclude the use of ketamine treatment. That said, ketamine is not advised for patients with schizophrenia or uncontrolled heart or blood pressure issues.

Our physicians review the medical history of each patient prior to treatment. All patients are closely monitored during treatments by an extensively trained clinical team to ensure the safety of the treatment. We discuss each patient’s medical history during the free informational call with an emergency-trained doctor from our team, and are happy to address any questions or concerns about medical complications.

At Ember, many of the patients we work with are navigating depression, and also have a trauma history or acute post-traumatic-stress-disorder (PTSD).

We highly recommend that patients with a trauma history are also actively working with a therapist who can meet with the patient in the days before and following treatment to help them prepare emotionally and integrate the emotions that may come up during the session.

The altered states of consciousness may surface suppressed memories, including traumas. While many patients find this extremely helpful to work through difficult histories, it reinforces the importance of feeling properly psychologically supported before, during, and after treatments. 

While a handful of trials have studied PTSD as the primary diagnosis, there is not yet the bulk of evidence that we would need to feel comfortable treatment PTSD without a concomitant diagnosis of depression.

At Ember, many of the patients we work with who are navigating depression have active suicidal ideation, and may have been hospitalized for prior suicidal ideation or failed suicide attempts.

IV ketamine can be an extraordinarily effective treatment for alleviating suicidal thinking, and many studies suggest the powerful role of ketamine as a treatment to address active suicidal ideation (SI).

Ember Health is an outpatient facility, and patients with SI must be considered stable enough for outpatient treatment to be seen at Ember Health. With that said, we can expedite the start of care for people with SI, and can activate care within 48 hours of outreach from a patient working with a care provider Ember has worked with before.

Learn more about who we can help here.

At Ember Health, we’ve worked with several patients who are seeking relief from postpartum depression. There is extensive safety data around ketamine for mother and child during this time, and we provide guidelines around safe breastfeeding.

Of greatest importance for mother and babies at this time, ketamine can provide relief within days of treatment, allowing for bonding with the baby in its critical first few weeks of life.

If this is a path you’d like to explore, we would work closely with your full mental health team to ensure an informed choice, with consideration of any risks involved for mother and child.

Ready to find relief?

Care at Ember​

The best way to learn more and understand whether you’re a fit for care is to schedule a free 20 minute consultation call with a doctor from our team. 

On the call, you will be able to share your situation and ask any questions about care with Ember. The doctor will introduce core concepts around ketamine for depression and care at Ember, and help assess whether you’re a fit for our care.

Ember Health is committed to a collaborative, team-based approach to each patient’s care.

This starts with an invitation for a call to each listed member of a patient’s care team who is new to working with Ember. We will not begin care for a patient until at least one licensed mental health provider confirms a diagnosis of depression, and agrees to collaborate in our shared patient’s care.

We provide informational materials to each provider partner about ketamine for depression, our care model at Ember, and how they can help their patient make the most of ketamine treatment. We solicit relevant inputs about the patient’s history to the extent it will help us ensure the best outcomes of care.

At the end of the Foundation, we solicit the advice of the provider team around how well they believe the patient responded to treatment. Over time, we inform the provider about the patient’s treatment cadence and mood over time, and we work as a team with the patient to adapt an individualized care plan which prioritizes the patient’s goals.

Outside of patient care, we invite mental health care collaborators to educational events, share relevant research in the field, and invite them to events which can deepen their understanding of their patients’ care, and build a sense of community.

You can learn more about how we partner with healthcare providers here.

At Ember Health, we use PHQ-9 surveys to track each patient’s mood as they progress through care with us. This is a self-report test with nine questions that can each score from 0 – 3 points, depending on the frequency of depressive symptoms. The final score can range from 0 (which indicates complete lack of depressive symptoms) to 27 (which is the most severe score). While there is no perfect way to measure or quantify depression, we use the PHQ-9 as it is among the most widely recognized measurement based outcomes tools.

We ask each patient to fill out this mood survey at multiple increments throughout the Foundation, and it plays a central role in determining treatment response, alongside qualitative feedback and provider input.

We send the PHQ-9 survey electronically every two weeks to patients who are actively in our care. Our team monitors inputs daily, and monitor for shifts in mood that would suggest depressive symptoms are recurring and it may be time for a booster infusion.

While starting ketamine infusion therapy, the concurrent use of other antidepressant medications will not interfere with ketamine’s effectiveness of addressing depressive symptoms, nor will it cause negative medication interactions.

One exception is that ketamine will not be as effective in addressing depressive symptoms for patients taking Benzodiazepines (trade names: Valium, Klonopin, Xanax, or Ativan). A handful of other medications may also decrease the effectiveness of ketamine.

We discuss medication history with each patient before treatment, and work with healthcare partners to suggest modifications of existing medication as appropriate.

Many patients who experience relief from ketamine have found that over time, they can reduce or eliminate other antidepressant medications. We advise each patient to tailor their unique medical treatment plan in partnership with their prescribing physician.

Each infusion appointment is 90-minutes long. Each patient is in a private infusion suite with 1:1 patient-to-clinician care during that time. The ketamine is infused for 40 of those minutes, and the remainder of the time is spent preparing for a calming, focused session, and taking stock of whatever came up during the altered state. We welcome patients to relax in a common reflection and recovery space following treatment for as long as the clinic is open.

An Ember Health clinician, professionally trained in IV administration and therapeutic communications, will be with you the entire time in a private infusion suite. See here our excellent team of compassionate care providers. We do not leave patients unattended during the entirety of their infusion.

For safety reasons, we do not allow friends, loved ones, or third party providers to accompany patients in the infusion suite. They may be in our waiting room, however, and we do our best to ensure they feel welcome and comfortable.

The vast majority of infusions at Ember Health are peaceful. The patient comfortably settles in the experience, in what many describe as a “cocoon like” state, and they enter an “inner-space.” Patients regularly describe the thought patterns that unfold as “being in therapy with themselves.”

The exact altered state experience varies widely from person to person, and from session to session. While some patients describe sessions as being highly visual and colorful, for others, the experiences are dull and muted. While some sessions can resurface memories and specific relationships or events, others feel conceptual and abstract. Despite these variations, patients express some common themes from the psychological content of the sessions.

 

  • Perspective Granting: Patients will talk about how sessions provide the opportunity to “zoom out” – to consider geologic time, and universal space – often making their own problems and lived experience feel small and relatively insignificant. Patients describe considering primary relationships from a different angle, or commonly held perceptions about one’s life being turned on their side. 
  • Meditative: Some patients have described sessions as a “cheat switch for meditation” where they are able to achieve a silencing of the inner narrator, a quieting of the mind, and an ability to be in the moment. Patients will describe looking at the vastness of a night sky in their mind’s eye or a wide open, vacant sea or landscape.
  • Connective: We often hear about an appreciation for inter-connectivity, the forces that unite all living things, and the impact these entities have on each other. This has been described at the molecular level, societal level, and about one’s personal relationships and life choices.
  • Reflective: Patients talk about the reflection in their mind’s eye of themselves and their primary relationships. Patients often describe feeling gratitude for people who have impacted them, or for various elements of their daily lives. Sessions may be reflective on memories of past events and experiences, sometimes from a third party perspective. Patients have told us of recalling repressed memories, or reflecting on past traumas.
  • Dream Like: Many patients relate to their experiences as they do their dreams, where they can recognize a collection of inputs and ideas that they may have encountered over the course of recent days or weeks. They may recount fantastical or bazaar settings.

Each experience is unique, and to date no data demonstrates that one type of experience is medically superior to another. We share these themes to give our patients and provider partners helpful language to describe what they may be experiencing.

See more about the patient experience at Ember here.

Patients express that they most often value therapy in the days leading up to treatment to help them prepare emotionally and logistically for care, and in the 24 – 72 hours following treatment to explore important topics that surfaced during the altered state. The neuroplastic window peaks at about 48 hours following treatment, making it a sweet-spot to work with therapy modalities that can help shift habits of thought and behavior. We provide resources and best practices for our therapist partners to help patients make the most of these sessions.

While most patients do not feel ready to engage in therapy sessions the same day as their treatment, and would prefer some time to reflect and process, some prefer to schedule therapy in the hours following their ketamine treatment when they feel “uninhibited” and ready to discuss topics they may regularly be guarded about.

Based on what we have heard from patients, there are a few ways you might recognize that ketamine is working over time:

  • You feel motivated to do small tasks that you’ve put off for weeks (e.g. respond to emails or clean out your closet)
  • You are open to the kinds of activities and engagements that have felt overwhelming (e.g. attending a party, catching up with a friend)
  • The normal negative thinking cycles aren’t weighing you down as they were before
  • External stressors and obstacles that once felt paralyzing are far more manageable
  • You aren’t expending energy trying to block out certain memories or traumas – they don’t feel terrifying anymore
  • You feel more present in your relationships (e.g. while playing with your child or caring for a loved one)
  • You’re finally “getting” what your therapist has been telling you for years

 

We assess treatment outcomes by reviewing the scores from your PHQ-9 mood surveys, talking to you about how you feel, and checking in with your mental health team. Every patient has a two week post-foundation call to discuss these outcomes and align on the best path forward based on the results.

Over the first few booster infusions you have in our care, we will be looking for a pattern of a consistent span before your symptoms return. While everyone is different, the median benefit of care is 6 weeks, and typical durations span from 2 – 20 weeks

Once we know your typical timing, our intention is to be preemptive about your treatments. For example, if your symptoms consistently return every eight weeks, we will advise scheduling treatments every seven weeks to catch you before your mood changes.

External events and circumstances (e.g. death in the family, divorce, job loss), may trigger depressive episodes early, before your regularly scheduled boosters. We are always here as a resource for you if you feel you need help building strength and resilience to cope with the stressors in your life.

In the same way, taking advantage of your improvements to make structural changes in your life can increase the spans of time between your visits. Committed to a personalized approach, we will continuously work with you to adjust your care plan based on your needs and goals.

Our aim is to serve as a partner to you in judging the right times to come in and designing a long term, flexible care plan that will help you feel like your best self with the constraints present in your life. We craft individualized care plans that summarize your responsiveness to treatment, and outline the next steps for you, for us, and for your larger mental health provider team. Our objective is to dis-ambiguate the challenging question of “when should I come back?” by giving clear guidelines.

We send mood surveys every two weeks to patients who are actively in our care, and closely monitor the results. This informs our recommendations for when patients should come back in for boosters. We also invite patients to reach out to us any time they may feel symptoms returning.

We founded Ember in 2018, and are still working with and providing sustained relief for patients who began care with us 6 years ago.

Cost of care

We charge $550 per treatment visit and $275 for a one-time orientation visit. Otherwise we do not charge for intake, care coordination, or any additional services outside of the office visit fees.

To make care as affordable as possible, we provide guidelines to people navigating their out of network insurance, which you can find here. About 70% of Ember patients receive out of network reimbursement through their insurance for our services, and on average, these people have 70% the cost of care reimbursed. For these individuals, the average cost of a single infusion is therefore $165 per session.

At Ember, we also offer a sliding scale program for people who do not have out of network benefits and who meet income-based criteria. To inquire about this program, we invite you to contact us at intake@emberhealth.co. 

To learn more, visit our pricing page here.

We are not aware of any insurance provider that will cover ketamine treatments in-network. That said, most people with out-of-network benefits under their health insurance plans are eligible to receive reimbursement for their care with us.

Out-of-network insurance can significantly offset the cost of care at Ember Health. On average, our clients who submit claims receive 70% reimbursement for our services. With that said, out-of-network reimbursement is notoriously confusing. We’ve provided guidelines here for how you can make the most of your out-of-network benefits.

Ember Health has also partnered with various employee benefits providers including Enthea and First Tracks Health. Employees of participating companies may receive up to full coverage for care at Ember.

Even though we’ve priced our services to maximize access, we recognize our fees are out of reach for many. We provide significantly reduced fees for up to 20% of our patients who do not have out-of-network benefits through an income-based sliding scale program. To inquire about this program, we invite you to contact us at intake@emberhealth.co. 

To learn more, visit our pricing page here.

We recognize that navigating the various options of ketamine for depression can be confusing, and that cost of care is a primary consideration for most people. At Ember Health, we are confident that we offer the greatest value per dollar spent to alleviate depression. This is due to the superior efficacy and durability of IV ketamine versus other routes of administration, and to our commitment to keeping patients safe.

We invite you to read more about our value of care here, which outlines critical questions for you to ask of any provider as you compare your options for ketamine care.

Most drugs start being covered in-network by insurance carriers once the Center for Medicaid or Medicare Services (CMS) begins covering the cost of the medication. For most drugs, CMS coverage is initiated when the FDA approves the drug on-label for a given indication.

IV ketamine is a generic drug which is already FDA approved for use as an anesthetic, and is covered by CMS when used in ambulatory settings. There is no known pathway for a generic drug to be approved by the FDA for another indication, no matter the bulk of evidence or data supporting its efficacy and safety.

There is a pathway, however, for CMS to consider coverage of drugs through direct appeal with clear evidence of efficacy, cost-effectiveness, and safety. In partnership with research institutions and advocates, Ember Health is committed to making the case for CMS coverage of IV ketamine for depression. This would be a watershed moment for in-network coverage, and make this critical treatment far more accessible to people who need it.

Making the case for CMS coverage of IV ketamine is a long, involved process, which requires many voices. If you feel compelled to join us in advocating for this kind of coverage, we welcome you to email us at community@emberhealth.co. 

Safety

Yes. Ketamine is used extensively in hospitals and clinics every day, and has been administered safely to millions of patients for decades. To ensure safety, ketamine infusions should be administered by medical professionals trained in anesthesia or emergency medicine, in a monitored setting.

During infusion, the most common side effect of ketamine is mild nausea. In rare cases, patients may experience allergic reactions, elevated blood pressures, elevated heart rate, or cardiac arrhythmia. A monitoring physician will intervene in the case of any of these effects FDA .

There are no known negative long-term effects of ketamine when used at the appropriate doses for depression and anesthesia. Select cases of long-term, daily use of ketamine by those who abuse the drug have shown some negative effects on the bladder and on cognition Yale .

There are no known negative long-term effects of ketamine when used at the appropriate doses for depression and anesthesia. Select cases of long-term, daily use of ketamine by those who abuse the drug have shown some negative effects on the bladder and on cognition Yale. This is not a risk for patients at Ember given the dosage and frequency of ketamine administration.

All of the Clinical Directors who lead Ember Health facilities are board certified, Emergency Medicine physicians, who are on site for all patient care. With extensive experience administering IV ketamine, medically monitoring patients, serving as the frontlines for acute mental health issues, and coordinating with a team of clinicians and consultant colleagues, EM physicians are uniquely positioned to lead our facilities.

All of our nurses have strong IV skills, as well as high EQ and therapeutic communications skills, particularly in handling emotional distress.

To learn more about our team, see here.

There are no routinely prescribed medications that are harmful when combined with ketamine. Ketamine has an excellent safety profile and few side effects. Patients are able to remain on their current oral antidepressant regimen when starting ketamine treatment.

Safety aside, there are a few medications that can affect ketamine’s antidepressant response: benzodiazepines, GABA-like substances, lamotrigine, and naltrexone are the most studied substances with these effects. 

Prescribers should always discuss with their patient whether it is advisable to keep taking an existing medication as prescribed, and the risks and benefits of any changes. We have provided more detail about medication interactions for our provider partners here.

We strongly advise that patients do not drive or operate any heavy machinery for at least 12 hours following treatment. Patients do often feel comfortable navigating public transportation to and from their appointments, however, and many choose to take a car service or walk. We welcome any loved ones who provide transport to patients to wait in our office during treatment.

Ketamine can be a drug of abuse for people seeking an altered mental state, particularly when people have access to the drug in a non-medical environment, without supervision of trained medical professionals.

Studies in humans show that daily ketamine use is associated with symptoms of addiction, including continued use despite knowing that it is causing problems, physically hazardous use, using more than intended, spending too much time obtaining or using ketamine, and tolerance, which is when more of a drug is needed for it to have the same effects. source

With medically supervised ketamine, when used infrequently as with mental health treatment protocols, there is no physical dependency established with the use of ketamine, and patients who stop using the drug do not experience physical symptoms of withdrawal WHO .

When administered in a medical context with supportive frameworks and guidelines, ketamine can be a safe, effective treatment to address depression for people who also have a substance use disorder. Some studies have even shown that IV ketamine can help lead to cessation of substance use, and discontinuation or shifting of harmful patterns of behavior around a range of substances. 

Ketamine is not a substance that causes physical symptoms of craving or withdrawal. The greatest risk of ketamine to people with an addiction history is that they may enjoy and seek the altered state experience. Outside of a medical context, this could lead to exposure to ketamine at higher frequency and dosage than is safe for people. At Ember, we only work with people who are not receiving ketamine from alternative sources. The most often we will treat patients under our protocols is once every two weeks, within safe, protocolized dosage windows. This frequency and dosage is not enough to establish detrimental patterns of abuse.

Yes, ketamine can be a safe, effective treatment for patients managing depression who also have a trauma history. About one in ten of our patients’ sessions at Ember have been self described as “difficult,” meaning that there may have been concepts or memories surfaced during the infusion that were challenging or uncomfortable. People with a trauma history often describe reviewing or even reliving a traumatic event in their mind’s eye. Patients have often described experiencing such events from an “emotionally neutral” standpoint or a different perspective, which gives them greater ability to talk about the events with their therapist. Many of our patients talk about difficult sessions as among the most therapeutic, putting into focus topics that they can work through in their reflective and healing process.

There are no known negative long-term effects of ketamine when used at the appropriate doses for depression and anesthesia. Select cases of long-term, daily use of ketamine by those who abuse the drug have shown some negative effects on the bladder and on cognition Yale . This is not a risk for patients at Ember given the dosage and frequency of ketamine administration.

Still have questions?